This conference offers numerous benefits for professionals in the life sciences and Tech IP sector.
Explore In-House Insights: Discover the valuable perspectives from leading companies such as Astellas, UCB, Sandoz, Novartis, Chiesi, Fresenius Kabi, and MSD, delivered directly by our distinguished in-house speaking faculty. Discover the valuable perspectives from leading companies across telecoms, consumer tech, NPEs, Med Tech and automotive/mobility.
Engage in Targeted Sessions: Dive into the most pressing pharma and biotech patent litigation topics, including preliminary injunctions (PIs), the Unified Patent Court (UPC), competition law, Supplementary Protection Certificates (SPCs), and biosimilars. Dive into the most pressing Tech patent litigation topics, including the UPC, interim licenses, SEP and FRAND enforcement topics, Trade Secrets and AI.
- Network with Top Firms: Gain insights from a diverse range of international and boutique patent litigation firms, participating as panellists and speakers, to enhance your understanding of the global litigation landscape.
- Tailor Your Strategy: Benefit from our new and improved tracked sessions on day 2, focusing on MedTech, small molecules, and large molecules, allowing you to craft a more personalized and effective patent litigation strategy.
- Hear from Key Decision-Makers: Learn directly from judicial and institutional speakers providing firsthand updates from critical bodies such as the UPC, UK courts, WIPO, EFPIA, the European Commission, and Medicines for Europe. Learn directly from judicial and institutional speakers providing firsthand updates from critical bodies such as the UPC, UK courts, WIPO and the European Commission